secwatch.observer — SEC 8-K summary
======================================

Issuer:     KYNTRA BIO, INC. (KYNB)
CIK:        0000921299
Form:       8-K
Filed at:   2024-09-06T23:59:59+00:00
Accession:  0000950170-24-104395
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

FibroGen terminates CFO Juan Graham and CMO Deyaa Adib as part of cost reduction plan
--------------------------------------------------------------------------------

- CFO Juan Graham and CMO Deyaa Adib given termination notice on Aug 30, 2024.
- Graham's departure date: Dec 15, 2024; Adib's departure date: Nov 1, 2024.
- Terminations are part of a cost reduction plan initiated Aug 2, 2024.
- Company states decisions not due to any disagreement with executives.
- Both will remain through transition periods.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921299/000095017024104395/0000950170-24-104395-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921299/000095017024104395/fgen-20240830.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-104395

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer